valproic acid has been researched along with Congenital Hyperinsulinism in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Congenital Hyperinsulinism: A familial, nontransient HYPOGLYCEMIA with defects in negative feedback of GLUCOSE-regulated INSULIN release. Clinical phenotypes include HYPOGLYCEMIA; HYPERINSULINEMIA; SEIZURES; COMA; and often large BIRTH WEIGHT. Several sub-types exist with the most common, type 1, associated with mutations on an ATP-BINDING CASSETTE TRANSPORTERS (subfamily C, member 8).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de las Heras, J | 1 |
Garin, I | 1 |
de Nanclares, GP | 1 |
Aguayo, A | 1 |
Rica, I | 1 |
CastaƱo, L | 1 |
Vela, A | 1 |
1 other study available for valproic acid and Congenital Hyperinsulinism
Article | Year |
---|---|
Familial hyperinsulinism-hyperammonemia syndrome in a family with seizures: case report.
Topics: Adult; Anticonvulsants; Child, Preschool; Congenital Hyperinsulinism; Family Health; Female; Glutama | 2010 |